This year’s FDA approval of the iLet Insulin Bionic Pancreas followed a 13-week randomized clinical trial conducted in San Antonio.
This year’s FDA approval of the iLet Insulin Bionic Pancreas followed a 13-week randomized clinical trial conducted in San Antonio.
When we work together, local journalism thrives.
Our goal is to reach $15,000 by July 31 to strengthen the future of San Antonio’s nonprofit media.
Will you join us?
📍 Local news that’s actually local.
We love San Antonio, just like you. Subscribe to our free daily newsletter for the latest headlines first thing every morning.
